Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.

Bart R J Van Dijken,Gilles N Stormezand,Alfred O Ankrah,Anouk Van Der Hoorn,Rudi A J O Dierckx,Peter Jan Van Laar,Kevin Camphausen

doi:10.1371/journal.pone.0264387

Bart R J Van Dijken, Gilles N Stormezand + Show 5 more

Open Access

https://doi.org/10.1371/journal.pone.0264387

Copy DOI

Abstract

11C-Methionine (11C-MET) PET prognostication of isocitrate dehydrogenase (IDH) wild type glioblastomas is inadequate as conventional parameters such as standardized uptake value (SUV) do not adequately reflect tumor heterogeneity. We retrospectively evaluated whether volume-based parameters such as metabolic tumor volume (MTV) and total lesion methionine metabolism (TLMM) outperformed SUV for survival correlation in patients with IDH wild type glioblastomas. Thirteen IDH wild type glioblastoma patients underwent preoperative 11C-MET PET. Both SUV-based parameters and volume-based parameters were calculated for each lesion. Kaplan-Meier curves with log-rank testing and Cox regression analysis were used for correlation between PET parameters and overall survival. Median overall survival for the entire cohort was 393 days. MTV (HR 1.136, p = 0.007) and TLMM (HR 1.022, p = 0.030) were inversely correlated with overall survival. SUV-based 11C-MET PET parameters did not show a correlation with survival. In a paired analysis with other clinical parameters including age and radiotherapy dose, MTV and TLMM were found to be independent factors. MTV and TLMM, and not SUV, significantly correlate with overall survival in patients with IDH wild type glioblastomas. The incorporation of volume-based 11C-MET PET parameters may lead to a better outcome prediction for this heterogeneous patient population.

Highlights

The use of amino acid PET such as L-methyl-11C-methionine (11C-MET) for prognostication of gliomas has recently been recommended [1]. 11C-MET PET has an excellent tumor-tobackground discrimination and provides supplementary metabolic information in addition to MRI [2].Survival and treatment strategies differ significantly among glioma patients, necessitating reliable preoperative prognostication [3]
standardized uptake value (SUV)-based 11C-MET PET parameters did not show a correlation with survival
The incorporation of volume-based 11C-MET PET parameters may lead to a better outcome prediction for this heterogeneous patient population

Summary

Methods

Thirteen IDH wild type glioblastoma patients underwent preoperative 11C-MET PET. Both SUV-based parameters and volume-based parameters were calculated for each lesion. Kaplan-Meier curves with log-rank testing and Cox regression analysis were used for correlation between PET parameters and overall survival

Results

Conclusions

Introduction

Discussion

Conclusion